A 62-year-old male with a long history of rosacea, which was well controlled on minocycline, presented to his primary care physician for routine examination. Physical examination was noted for non-palpable, non-pruritic blue patches of hyperpigmentation on the medial aspects of his lower extremities bilaterally. Recognition and management of the findings are discussed.

Introduction Postsclerotherapy hyperpigmentation following the treatment of either varicose veins and/or visible blood vessles (telangiectasias) in the lower limbs has always been a major problem for the phlebologist. In literature there are conflicting data on the true incidence of this complication. In some studies the incidence is estimated in 30% of patients treated with sodium tetradecyl s...

Amlodipine is a potent peripheral and coronary vasodilator with high selectivity for vascular smooth muscle, and is widely used in mild to moderate hypertension, chronic stable angina and vasospastic angina. Its most prevalent side effects are peripheral edema, flushing and headache. Cutaneous adverse reactions associated with amlodipine have been rarely reported. Herein, a male patient is desc...

Acne is the most common skin condition in United States, affecting up to 90% of people at some point their lives. It frequently accompanied by post-inflammatory hyperpigmentation, which affects color with greater severity. Tetracyclines are widely prescribed oral antibiotics for acne and have been proven effective against moderate severe inflammatory subtypes, but previous studies shown that te...